StaffApril 19, 2018
Here is your Daily Hit of cannabis news for April 19, 2018: On The Site: GW Pharmaceuticals Inc. GW Pharmaceuticals Inc. (GWPH) continues to get closer and closer to FDA approval of its drug Epidiolex for the rare forms of epilepsy Lennox-Gastaut and Dravet Syndrome. Epidiolex is GW’s lead cannabinoid product candidate and is a pharmaceutical formulation […]